IN THE SPOTLIGHT
June 2021 Humacyte Investor Update
press & news coverage
June 10, 2021
Humacyte to Participate in Fireside Chat at Cowen 6th Annual FutureHealth Conference
June 08, 2021
Humacyte Presents In Vivo Data on Biovascular Pancreas Transplantation for Type 1 Diabetes Treatment
May 22, 2021
Humacyte Announces Presentation by Principal Investigator Highlighting Clinical Experience with HAVs at Vascular Access Society of the Americas 2021 Spring Conference
May 06, 2021
Humacyte Leadership and Investigators to Present at Five Scientific Events in May
April 21, 2021
Humacyte Announces Positive Long-Term Follow-Up Data from Phase 2 Vascular Access Trial
March 23, 2021
Humacyte CEO Dr. Laura Niklason and Alpha Healthcare CEO Rajiv Shukla to Present at CED Venture Connect 2021 Online Summit
March 5, 2021
Humacyte to Present Long-Term Follow-Up Data from Phase 2 Vascular Access Trial at Charing Cross (CX) International Symposium 2021
February 17, 2021
Humacyte, a Transformative Biotechnology Platform Company Capable of Manufacturing Universally Implantable Bioengineered Human Tissue at Commercial Scale, Going Public via Merger with Alpha Healthcare Acquisition Corp.
January 12, 2021
Humacyte CEO Dr. Laura Niklason to Present Virtually at ICR Conference Jan 14
January 10, 2021
Humacyte CEO Dr. Laura Niklason to Present at J.P. Morgan Healthcare Conference January 11
November 20, 2020
Humacyte Appoints Founder Laura Niklason MD, PhD as President and Chief Executive Officer
March 2, 2020
Humacyte Founder Laura Niklason, M.D., Ph.D. Elected to National Academy of Engineering
April 8, 2019
Humacyte Awarded ‘Large Project Prototype of the Year’ from The Medical Technology Enterprise Consortium
March 29, 2019
Science Translational Medicine Publishes Results That Humacyte’s “Human Acellular Vessels Recellularize and Evolve into Living Blood Vessels following Human Implantation"
December 1, 2020
Humacyte’s Bioengineered Blood Vessel Implanted by Clinicians at Walter Reed to Restore Blood Circulation to Retired Military Veteran’s Leg
October 20, 2020
Humacyte and CNTR Team on MTEC Grant to Study the Evidence on Repair of Vascular Trauma
February, 2020
Humacyte Founder Laura Niklason, M.D., Ph.D. Elected to National Academy of Engineering
May 22, 2019
Surgeons Perform First Bioengineered Blood Vessel Transplant in Military Patient
May 10, 2019
Bioengineered blood vessels could replace vasculature damaged by renal failure, CVD
April 9, 2019
Artificial blood vessels that come to life could improve medical care. Here’s why
March 29, 2019
Study finds Humacyte acellular vessels repopulated to create living vessels
